|
Alzheimer Disease
Contributing journals to this collection:
JAMA & Archives Journals
Citations 391-400 of 695 total displayed.
- Original Contributions
Memantine Treatment in Patients With Moderate to Severe Alzheimer Disease Already Receiving Donepezil: A Randomized Controlled Trial
- Pierre N. Tariot; Martin R. Farlow; George T. Grossberg; Stephen M. Graham; Scott McDonald; Ivan Gergel
JAMA 2004; 291: 317-324.
[Abstract]
[Full text]
[PDF]
- Editor's Correspondence
Obesity and Alzheimer Disease: Roles of Diet and Genetics
- William B. Grant
Arch Intern Med 2004; 164: 109-a-110-a.
[Extract]
[Full text]
[PDF]
- Editor's Correspondence
Obesity and Alzheimer Disease: Roles of Diet and Genetics—Reply
- Deborah Gustafson; Ingmar Skoog
Arch Intern Med 2004; 164: 110.
[Extract]
[Full text]
[PDF]
- Original Contributions
Mild Cognitive Impairment Can Be Distinguished From Alzheimer Disease and Normal Aging for Clinical Trials
- Michael Grundman; Ronald C. Petersen; Steven H. Ferris; Ronald G. Thomas; Paul S. Aisen; David A. Bennett; Norman L. Foster; Clifford R. Jack Jr; Douglas R. Galasko; Rachelle Doody; Jeffrey Kaye; Mary Sano; Richard Mohs; Serge Gauthier; Hyun T. Kim; Shelia Jin; Arlan N. Schultz; Kimberly Schafer; Ruth Mulnard; Christopher H. van Dyck; Jacobo Mintzer; Edward Y. Zamrini; Deborah Cahn-Weiner; Leon J. Thal
Arch Neurol 2004; 61: 59-66.
[Abstract]
[Full text]
[PDF]
- Original Contributions
Cognitive Reserve–Mediated Modulation of Positron Emission Tomographic Activations During Memory Tasks in Alzheimer Disease
- Nikolaos Scarmeas; Eric Zarahn; Karen E. Anderson; Lawrence S. Honig; Aileen Park; John Hilton; Joseph Flynn; Harold A. Sackeim; Yaakov Stern
Arch Neurol 2004; 61: 73-78.
[Abstract]
[Full text]
[PDF]
- Original Contributions
Reduced Risk of Alzheimer Disease in Users of Antioxidant Vitamin Supplements: The Cache County Study
- Peter P. Zandi; James C. Anthony; Ara S. Khachaturian; Stephanie V. Stone; Deborah Gustafson; JoAnn T. Tschanz; Maria C. Norton; Kathleen A. Welsh-Bohmer; John C. S. Breitner
Arch Neurol 2004; 61: 82-88.
[Abstract]
[Full text]
[PDF]
- Original Articles
Measurement of Phosphorylated Tau Epitopes in the Differential Diagnosis of Alzheimer Disease: A Comparative Cerebrospinal Fluid Study
- Harald Hampel; Katharina Buerger; Raymond Zinkowski; Stefan J. Teipel; Alexander Goernitz; Niels Andreasen; Magnus Sjoegren; John DeBernardis; Daniel Kerkman; Koichi Ishiguro; Hideto Ohno; Eugeen Vanmechelen; Hugo Vanderstichele; Cheryl McCulloch; Hans-Jürgen Möller; Peter Davies; Kaj Blennow
Arch Gen Psychiatry 2004; 61: 95-102.
[Abstract]
[Full text]
[PDF]
- Editorials
Metal Chelation Therapy for Alzheimer Disease
- Roger N. Rosenberg
Arch Neurol 2003; 60: 1678-1679.
[Extract]
[Full text]
[PDF]
- Original Contributions
Metal-Protein Attenuation With Iodochlorhydroxyquin (Clioquinol) Targeting A Amyloid Deposition and Toxicity in Alzheimer Disease: A Pilot Phase 2 Clinical Trial
- Craig W. Ritchie; Ashley I. Bush; Andrew Mackinnon; Steve Macfarlane; Maree Mastwyk; Lachlan MacGregor; Lyn Kiers; Robert Cherny; Qiao-Xin Li; Amanda Tammer; Darryl Carrington; Christine Mavros; Irene Volitakis; Michel Xilinas; David Ames; Stephen Davis; Konrad Beyreuther; Rudolph E. Tanzi; Colin L. Masters
Arch Neurol 2003; 60: 1685-1691.
[Abstract]
[Full text]
[PDF]
- Original Contributions
Cerebrospinal Fluid Tau and -Amyloid: How Well Do These Biomarkers Reflect Autopsy-Confirmed Dementia Diagnoses?
- Christopher M. Clark; Sharon Xie; Jesse Chittams; Douglas Ewbank; Elaine Peskind; Douglas Galasko; John C. Morris; Daniel W. McKeel Jr; Martin Farlow; Sharon L. Weitlauf; Joseph Quinn; Jeffrey Kaye; David Knopman; Hiroyuki Arai; Rachelle S. Doody; Charles DeCarli; Susan Leight; Virginia M.-Y. Lee; John Q. Trojanowski
Arch Neurol 2003; 60: 1696-1702.
[Abstract]
[Full text]
[PDF]
|
Advertisement
|
|
|
